Diabetes Care:ADA和AGA公布老年2型糖尿病防治共识

2012-11-07 佚名 中华医学会糖尿病学分会

  10月25日,美国糖尿病学会(ADA)和美国老年医学会(AGA)联合公布有关老年糖尿病的共识报告,强调在为老年2型糖尿病患者制定治疗目标时,应考虑预期剩余寿命和合并症等因素,充分体现了个体化及以患者为中心的原则。(Diabetes Care;J Am Geriatr Soc.2012年10月25日在线版)   根据合并症、认知和体能等情况,作者将老年糖

  10月25日,美国糖尿病学会(ADA)和美国老年医学会(AGA)联合公布有关老年糖尿病的共识报告,强调在为老年2型糖尿病患者制定治疗目标时,应考虑预期剩余寿命和合并症等因素,充分体现了个体化及以患者为中心的原则。(Diabetes Care;J Am Geriatr Soc.2012年10月25日在线版)

  根据合并症、认知和体能等情况,作者将老年糖尿病患者分为3种情况:身体健康,即无慢性合并症以及认知功能和体能状态良好;身体状况复杂或中等,即多种慢性合并症,或日常基本活动障碍≥2个,或轻中度认知功能受损;即身体极其复杂/差,合并需长期护理或终末期慢性疾病,或中重度认知功能障碍,或日常基本活动障碍≥2个。基于上述3种情况和患者预期剩余寿命,该共识分别提出了不同的血糖、血压和血脂控制目标。例如,第一种患者预期寿命较长,其糖化血红蛋白(HbA1c)水平应控制在7.5%以下;对于第2种患者,HbA1c水平应放宽至8%,以减少低血糖和跌倒;第3种患者预期寿命有限,治疗获益不明确,HbA1c水平可能低于8.5%就足够了。

  链接:

Sue Kirkman M, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, Pratley RE, Swift CS.Diabetes in Older Adults: A Consensus Report.J Am Geriatr Soc. 2012 Oct 25. doi: 10.1111/jgs.12035

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1759210, encodeId=c29f1e5921063, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 12 13:05:00 CST 2013, time=2013-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976319, encodeId=432919e6319bb, content=<a href='/topic/show?id=1bc680101d7' target=_blank style='color:#2F92EE;'>#老年2型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80101, encryptionId=1bc680101d7, topicName=老年2型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Sat Sep 07 19:05:00 CST 2013, time=2013-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636586, encodeId=b6e3163658628, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Feb 26 07:05:00 CST 2013, time=2013-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062350, encodeId=1cde2062350a9, content=<a href='/topic/show?id=2198208e64' target=_blank style='color:#2F92EE;'>#AGA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2087, encryptionId=2198208e64, topicName=AGA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Feb 12 21:05:00 CST 2013, time=2013-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901019, encodeId=d45c190101952, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Jan 25 18:05:00 CST 2013, time=2013-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264453, encodeId=39951264453fd, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Nov 09 01:05:00 CST 2012, time=2012-11-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1759210, encodeId=c29f1e5921063, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 12 13:05:00 CST 2013, time=2013-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976319, encodeId=432919e6319bb, content=<a href='/topic/show?id=1bc680101d7' target=_blank style='color:#2F92EE;'>#老年2型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80101, encryptionId=1bc680101d7, topicName=老年2型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Sat Sep 07 19:05:00 CST 2013, time=2013-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636586, encodeId=b6e3163658628, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Feb 26 07:05:00 CST 2013, time=2013-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062350, encodeId=1cde2062350a9, content=<a href='/topic/show?id=2198208e64' target=_blank style='color:#2F92EE;'>#AGA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2087, encryptionId=2198208e64, topicName=AGA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Feb 12 21:05:00 CST 2013, time=2013-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901019, encodeId=d45c190101952, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Jan 25 18:05:00 CST 2013, time=2013-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264453, encodeId=39951264453fd, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Nov 09 01:05:00 CST 2012, time=2012-11-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1759210, encodeId=c29f1e5921063, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 12 13:05:00 CST 2013, time=2013-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976319, encodeId=432919e6319bb, content=<a href='/topic/show?id=1bc680101d7' target=_blank style='color:#2F92EE;'>#老年2型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80101, encryptionId=1bc680101d7, topicName=老年2型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Sat Sep 07 19:05:00 CST 2013, time=2013-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636586, encodeId=b6e3163658628, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Feb 26 07:05:00 CST 2013, time=2013-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062350, encodeId=1cde2062350a9, content=<a href='/topic/show?id=2198208e64' target=_blank style='color:#2F92EE;'>#AGA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2087, encryptionId=2198208e64, topicName=AGA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Feb 12 21:05:00 CST 2013, time=2013-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901019, encodeId=d45c190101952, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Jan 25 18:05:00 CST 2013, time=2013-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264453, encodeId=39951264453fd, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Nov 09 01:05:00 CST 2012, time=2012-11-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1759210, encodeId=c29f1e5921063, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 12 13:05:00 CST 2013, time=2013-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976319, encodeId=432919e6319bb, content=<a href='/topic/show?id=1bc680101d7' target=_blank style='color:#2F92EE;'>#老年2型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80101, encryptionId=1bc680101d7, topicName=老年2型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Sat Sep 07 19:05:00 CST 2013, time=2013-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636586, encodeId=b6e3163658628, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Feb 26 07:05:00 CST 2013, time=2013-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062350, encodeId=1cde2062350a9, content=<a href='/topic/show?id=2198208e64' target=_blank style='color:#2F92EE;'>#AGA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2087, encryptionId=2198208e64, topicName=AGA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Feb 12 21:05:00 CST 2013, time=2013-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901019, encodeId=d45c190101952, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Jan 25 18:05:00 CST 2013, time=2013-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264453, encodeId=39951264453fd, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Nov 09 01:05:00 CST 2012, time=2012-11-09, status=1, ipAttribution=)]
    2013-02-12 vera_1203
  5. [GetPortalCommentsPageByObjectIdResponse(id=1759210, encodeId=c29f1e5921063, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 12 13:05:00 CST 2013, time=2013-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976319, encodeId=432919e6319bb, content=<a href='/topic/show?id=1bc680101d7' target=_blank style='color:#2F92EE;'>#老年2型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80101, encryptionId=1bc680101d7, topicName=老年2型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Sat Sep 07 19:05:00 CST 2013, time=2013-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636586, encodeId=b6e3163658628, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Feb 26 07:05:00 CST 2013, time=2013-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062350, encodeId=1cde2062350a9, content=<a href='/topic/show?id=2198208e64' target=_blank style='color:#2F92EE;'>#AGA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2087, encryptionId=2198208e64, topicName=AGA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Feb 12 21:05:00 CST 2013, time=2013-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901019, encodeId=d45c190101952, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Jan 25 18:05:00 CST 2013, time=2013-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264453, encodeId=39951264453fd, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Nov 09 01:05:00 CST 2012, time=2012-11-09, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1759210, encodeId=c29f1e5921063, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 12 13:05:00 CST 2013, time=2013-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976319, encodeId=432919e6319bb, content=<a href='/topic/show?id=1bc680101d7' target=_blank style='color:#2F92EE;'>#老年2型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80101, encryptionId=1bc680101d7, topicName=老年2型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Sat Sep 07 19:05:00 CST 2013, time=2013-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636586, encodeId=b6e3163658628, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Feb 26 07:05:00 CST 2013, time=2013-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062350, encodeId=1cde2062350a9, content=<a href='/topic/show?id=2198208e64' target=_blank style='color:#2F92EE;'>#AGA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2087, encryptionId=2198208e64, topicName=AGA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Feb 12 21:05:00 CST 2013, time=2013-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901019, encodeId=d45c190101952, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Jan 25 18:05:00 CST 2013, time=2013-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264453, encodeId=39951264453fd, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Nov 09 01:05:00 CST 2012, time=2012-11-09, status=1, ipAttribution=)]
    2012-11-09 般若傻瓜